Colony Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $4.57M | Sell |
|
|||||
|
2023
Q2 | $3.91M | Buy |
|
|||||
|
2023
Q1 | $4.19M | Buy |
|
|||||
|
2022
Q4 | $998K | Buy |
|
|||||
|
2022
Q3 | $734K | Sell |
|
|||||
|
2022
Q2 | $674K | Buy |
|
|||||
|
2022
Q1 | $648K | Sell |
|
|||||
|
2021
Q4 | $605K | Sell |
|
|||||
|
2021
Q3 | $724K | Hold |
|
|||||
|
2021
Q2 | $735K | Hold |
|
|||||
|
2021
Q1 | $734K | Buy |
|
|||||
|
2020
Q4 | $688K | Sell |
|
|||||
|
2020
Q3 | $819K | Sell |
|
|||||
|
2020
Q2 | $1.11M | Sell |
|
|||||
|
2020
Q1 | $796K | Sell |
|
|||||
|
2019
Q4 | $1.08M | Sell |
|
|||||
|
2019
Q3 | $1.42M | Sell |
|
|||||
|
2019
Q2 | $1.43M | Buy |
|